Author:
Sezer Ilhan,Kocabas Hilal,Melikoglu Meltem Alkan,Arman Mehmet
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference17 articles.
1. Hamılton CD (2003) Tuberculosis in the cytokine era: what rheumatologists need to know. Arthritis Rheum 48:2085–2091
2. Imperato AK, Smıles S, Abramson SB (2004) Long-term risks associated with biologic response modifiers used in rheumatic diseases. Curr Opin Rheumatol 16:199–205
3. Panayi G, Corrigall V, Pitzalis C (2001) Pathogenesis of rheumatoid arthritis. The role of T cells and others beasts. Rheum Dis Clin North Am 27:1–18
4. Ponce de León D, Acevedo-Vásquez E, Sánchez-Torres A, Cucho M, Alfaro J, Perich R et al (2005) Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 64:1360–1361
5. Köker IH, Pamuk ON, Karlikaya C, Tunçbilek N, Cakir N (2007) A low prevalence of purified protein derivative test positivity in Turkish patients with rheumatoid arthritis. Association with clinical features and HRCT findings. Clin Exp Rheumatol 25:54–59
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献